ASA: Stem Cell Transplant Improves Vasculopathy in Sickle Cell Patients

THURSDAY, Feb. 9, 2023 -- For adults with sickle cell disease (SCD), hematopoietic stem cell transplantation (HSCT) seems to improve or prevent development of vasculopathies, according to a study presented at the American Stroke Association...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news